Hepatic encephalopathy: current status.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000596:Amino Acids / Q000378:metabolism; D000641:Ammonia / Q000097:blood; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001679:Biogenic Amines / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004232:Diuretics / Q000009:adverse effects; D004734:Energy Metabolism; D005078:Exchange Transfusion, Whole Blood; D005227:Fatty Acids / Q000378:metabolism; D006501:Hepatic Encephalopathy / Q000209:etiology* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D007422:Intestines / Q000382:microbiology / Q000601:surgery; D007792:Lactulose / Q000627:therapeutic use; D008107:Liver Diseases / Q000378:metabolism; D009461:Neurologic Manifestations; D010101:Oxygen Consumption; D011167:Portacaval Shunt, Surgical
D000305:Adrenal Cortex Hormones; D000596:Amino Acids; D000900:Anti-Bacterial Agents; D001679:Biogenic Amines; D004232:Diuretics; D005227:Fatty Acids; D006993:Hypnotics and Sedatives; D007792:Lactulose; D004295:Dihydroxyphenylalanine; D000641:Ammonia